ADVFN ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Caratteristiche principali

Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Repligen Corp

Repligen Corp (RGEN)

122,31
-4,24
(-3,35%)
Chiuso 06 Giugno 10:00PM
122,31
-0,06
(-0,05%)
Dopo le ore di negoziazione: 1:59AM

Repligen Corp (RGEN) Operazioni degli insider

-
Filtra per:
Data Nome del titolare Azioni transazionate Intervallo di valore ($) Tipo di transazione Intervallo di prezzo ($) Azioni a fine dichiarazione % di variazione
2026-05-07Mr. Glenn P. MuirIndependent Director2,43k94,34kDerivative Exercise and Retained Stock38,7638,08k6,83%
2026-05-07Mr. Brian DouglassSenior VP & Chief Product Officer-334,0042,23kSale to Issuer126,431,61k-17,20%
2026-04-21Mr. Olivier LoeillotPresident, CEO & Director-3,83k536,48kVendita140,001,00-99,97%
2026-03-04Mr. James R. BylundCOO-62,007,80kSale to Issuer125,8417,67k-0,35%
2026-03-04Mr. Ralf KuriyelSVP of Research & Development-42,005,29kSale to Issuer125,8414,78k-0,28%
2026-02-27Mr. James R. BylundCOO-3,91k494,31kSale to Issuer124,97 - 128,738,28k-32,09%
2026-02-27Mr. Olivier LoeillotPresident, CEO & Director-1,95k245,48kSale to Issuer124,97 - 128,7333,94k-5,44%
2026-03-02Mr. Anthony J. HuntAdvisor-9,90k1,24MSale to Issuer124,9782,49k-10,71%
2026-02-27Mr. Jason K. GarlandCFO & CCO-1,04k131,45kSale to Issuer124,97 - 128,733,90k-21,07%
2026-02-27Mr. Ralf KuriyelSVP of Research & Development-1,37k172,50kSale to Issuer124,97 - 128,7314,70k-8,51%
2026-03-02Mr. Brian DouglassSenior VP & Chief Product Officer-221,0027,62kSale to Issuer124,971,14k-16,21%
2025-12-17Ms. Karen Anne T. DawesLead Independent Director-275,0044,28kVendita161,0090,85k-0,30%
2025-12-16Mr. Glenn P. MuirIndependent Director3,37k87,92kDerivative Exercise and Retained Stock26,1235,65k10,43%
2025-12-04Mr. Anthony J. HuntAdvisor-2,00k0,00Other Disposition-79,35k-2,46%
2025-11-25Mr. Olivier LoeillotPresident, CEO & Director-7,04k1,20MVendita170,000,00-100,00%
2025-11-18Mr. James R. BylundCOO-2,19k331,30kVendita151,216,51k-25,19%
2025-11-13Mr. Anthony J. HuntAdvisor2,95k99,98kDerivative Exercise and Retained Stock33,8764,09k4,83%
2025-11-13Mr. Anthony J. HuntAdvisor-20,00k3,09MVendita151,01 - 157,1164,09k-23,79%
2025-11-12Mr. Anthony J. HuntAdvisor-25,00k3,08MDerivative Exercise and Sale33,87 - 158,5181,13k-
2025-10-02Mr. Olivier LoeillotPresident, CEO & Director-1,25k181,25kSale to Issuer145,237,04k-15,06%
2025-09-25Mr. Jason K. GarlandCFO & CCO-412,0050,13kSale to Issuer121,681,95k-17,42%
2025-09-10Mr. Anthony J. HuntAdvisor-20,00k1,72MDerivative Exercise and Sale33,87 - 121,4281,13k-
2025-09-10Mr. Anthony J. HuntAdvisor-9,11k1,11MVendita121,42 - 122,2381,13k-10,10%
2025-09-03Mr. Olivier LoeillotPresident, CEO & Director-2,51k291,15kSale to Issuer116,185,71k-30,51%
2025-08-08Dr. Martin D. MadausIndependent Chair of the Board1,80k201,83kAcquisto112,136,42k38,93%